Virtua Health installs innovative GE HealthCare systems to advance cardiac imaging in southern New Jersey

February 26, 2024
CHICAGO — February 26, 2024 —GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, today announced that New Jersey-based Virtua Health has installed the innovative Omni Legend digital PET/CT– the first Omni Legend PET/CT system in New Jersey– and Revolution Apex platform – a CT system capable of 1-beat cardiac imaging – to add advanced capabilities to their cardiology facility in Moorestown, New Jersey. Not-for-profit Virtua Health is the largest health system in southern New Jersey and seeks to leverage this innovative technology to advance heart imaging in the Greater Philadelphia area.

With cardiovascular disease as the leading cause of death globally, the prevalence of cardiovascular disease doubling since 1990, and a predicted increase in prevalence as the population ages, it is crucial to take a solutions-oriented approach to wellness, prevention, and early detection in cardiovascular health. [i, ii}

“The highest quality of cardiovascular imaging matters because it helps us more accurately diagnose a patient’s heart condition,” says Virtua cardiologist Mark Finch, MD, FACC. “From there, we can establish the best possible care pathway, whether that’s medication, lifestyle modification, or medical intervention. The more information we’re able to analyze, the better our patient outcomes can become. That’s why we’re excited to add these innovative GE HealthCare systems to our facility and help improve quality of life for those we care for.”

Cardiology care is complex, and the solutions built to address cardiovascular disease are evolving rapidly. That’s why GE HealthCare provides systems that help to tell the story of the heart. The Omni Legend PET/CT and the Revolution Apex CT both can help leverage research, data, and the potential of artificial intelligence (AI) to drive care pathway optimization and help deliver better patient care, notably in the detection and diagnosis phase which is an important step in informing treatment plans

“GE HealthCare is devoted to providing cardiology solutions that support the continuum of care and personalize treatment around the world and certainly at outpatient facilities like Virtua Cardiology,” said Scott Stoddard, New York and Philadelphia Market Vice President at GE HealthCare. “The new Omni Legend PET/CT and Revolution Apex platform systems at Virtua represent meaningful improvements in cardiac imaging that can power clinical efficiencies and better patient outcomes.”

Achieving Efficiency and Consistency in Imaging
The Omni Legend PET/CT is an innovative technology built from the ground up to harness the power of an advanced digital detector capable of producing high-resolution images and exceptional image quality. This system delivers more than two times the sensitivity of prior digital scanners with a similar axial field of view [iii], enabling faster total scan times[iv] and increased small lesion detectability[v]. It is designed to help improve operational efficiency, patient experience, and diagnostic confidence, ideally helping to enable improved patient outcomes.

Revolution Apex platform was also developed with operational efficiency in mind. Studying radiology departments’ entire workflows and identifying opportunities to simplify and streamline processes, GE HealthCare developed Effortless Workflow, which utilizes AI technologies to automate time-consuming tasks, from pre-scan to post-scan – helping to reduce clicks, save time, and achieve exceptional efficiency and consistency in imaging[vi]. Revolution Apex platform is also designed to produce high quality CT images TrueFidelity, an impressive image reconstruction technology that uses a dedicated Deep Neural Network to generate high-definition, low-noise CT images. TrueFidelity produces images with exceptional sharpness, low-contrast performance, and preferred noise texture, even with low dose [iv].


About Virtua Health:
Virtua Health is an academic health system committed to helping the people of South Jersey be well, get well, and stay well by providing the complete spectrum of advanced, accessible, and trusted health care services. Virtua’s 14,000 colleagues provide tertiary care, including renowned cardiology and transplant programs, complemented by a community-based care portfolio. In addition to five hospitals, two satellite emergency departments, 41 ambulatory surgery centers, and more than 350 other locations, Virtua brings health services directly into communities through Hospital at Home, physical therapy and rehabilitation, mobile screenings, and its paramedic program.

Virtua has 2,850 affiliated doctors and other clinicians, and its specialties include orthopedics, advanced surgery, and maternity. Virtua is academically affiliated with Rowan University, leading research, innovation, and immersive education at the Virtua Health College of Medicine & Life Sciences of Rowan University. Virtua is also affiliated with Penn Medicine for cancer and neuroscience, and the Children’s Hospital of Philadelphia for pediatrics.

As a not-for-profit, Virtua is committed to the well-being of the community and provides innovative outreach programs that address social challenges affecting health, most notably the “Eat Well” food access initiative, which includes the unparalleled Eat Well Mobile Grocery Store. Discover more at virtua.org.


About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with 51,000 colleagues working to create a world where healthcare has no limits.